Menstrual problems in chronic immune thrombocytopenia: A monthly challenge - a cohort study and review
- PMID: 35662003
- PMCID: PMC9540539
- DOI: 10.1111/bjh.18291
Menstrual problems in chronic immune thrombocytopenia: A monthly challenge - a cohort study and review
Abstract
Immune thrombocytopenia (ITP) may cause menstrual problems. This cross-sectional study assessed menstrual problems in premenopausal chronic ITP women by several questionnaires, including the pictorial bleeding assessment calendar (PBAC; score ≥100 indicates heavy menstrual bleeding [HMB]), and the menorrhagia multiattribute scale (MMAS). Spearman was used for assessing correlations. A literature review was performed in Pubmed. The cohort comprised 37 women (mean age 31 ± 9). A total of 29/37 (78%) had experienced clinical menstrual problems in the present or past. Of the 33 patients who returned the PBAC, 13 (39%) had a score of ≥100. The median MMAS score was 79 (IQR 60-95). The PBAC scores correlated with the MMAS. Both questionnaires were unrelated to the platelet count. Patients with a levonorgestrel intrauterine device (LNG-IUD) had lower PBAC scores than patients with other or no hormonal therapy. MMAS scores were correlated with fatigue. The review identified 14 papers. HMB occurred in 6%-55% at ITP diagnosis and 17%-79% during disease. Menstrual symptoms influenced the quality of life, particularly in patients with a low platelet count. This explorative study suggested that HMB is frequent in women with chronic ITP despite management and platelet counts >50 *109 /l. An LNG-IUD seemed to reduce blood loss significantly.
Keywords: heavy menstrual bleeding; immune thrombocytopenia; menstrual problems; menstruation; quality of life.
© 2022 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd.
Conflict of interest statement
R.E.G. Schutgens received a grant from Novartis. The other authors have no potential conflicts of interest to declare.
Figures



Similar articles
-
[Analysis of management efficacy in patients with heavy menstrual bleeding associated with antithrombotic therapy].Zhonghua Fu Chan Ke Za Zhi. 2023 Apr 25;58(4):286-292. doi: 10.3760/cma.j.cn112141-20221130-00725. Zhonghua Fu Chan Ke Za Zhi. 2023. PMID: 37072297 Chinese.
-
Quality of Life of Japanese Dysmenorrhea/Heavy Menstrual Bleeding Patients Treated with Levonorgestrel Intrauterine Delivery System in a Real-World Setting.Adv Ther. 2022 Aug;39(8):3616-3634. doi: 10.1007/s12325-022-02205-2. Epub 2022 Jun 16. Adv Ther. 2022. PMID: 35705788 Free PMC article.
-
Bleeding patterns of women with heavy menstrual bleeding or dysmenorrhoea using the levonorgestrel-releasing intrauterine system: results from a real-world observational study in Japan (J-MIRAI).Eur J Contracept Reprod Health Care. 2022 Aug;27(4):300-307. doi: 10.1080/13625187.2022.2067329. Epub 2022 May 25. Eur J Contracept Reprod Health Care. 2022. PMID: 35611632
-
Treatment of Women With an Endometrial Polyp and Heavy Menstrual Bleeding: A Levonorgestrel-Releasing Intrauterine Device or Hysteroscopic Polypectomy?J Minim Invasive Gynecol. 2015 Nov-Dec;22(7):1153-62. doi: 10.1016/j.jmig.2015.06.016. Epub 2015 Jul 4. J Minim Invasive Gynecol. 2015. PMID: 26151760 Review.
-
Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.Contraception. 1995 Nov;52(5):269-76. doi: 10.1016/0010-7824(95)00210-2. Contraception. 1995. PMID: 8585882 Review.
Cited by
-
Burden of immune thrombocytopenia (ITP): Special considerations for refractory ITP.Br J Haematol. 2023 Oct;203(1):79-85. doi: 10.1111/bjh.19068. Br J Haematol. 2023. PMID: 37735553 Free PMC article. Review.
-
Primary Hemostasis Disorders as a Cause of Heavy Menstrual Bleeding in Women of Reproductive Age.J Clin Med. 2023 Sep 1;12(17):5702. doi: 10.3390/jcm12175702. J Clin Med. 2023. PMID: 37685769 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous